The Union Health and Family Welfare Ministry has launched new anti-TB (Tuberculosis) drug Bedaquiline
It was launched by the Union Health Minister J P Nadda as part of the TB national programme
Initially the drug will be made available in six public hospitals in Delhi, Mumbai, Chennai, Guwahati and Ahmedabad. Later it will be introduced in 104 districts across five States.
Bedaquiline is a new anti-TB drug for treatment of Multi-drug-resistant tuberculosis. It specifically targets Mycobacterial ATP synthase, an enzyme which is essential for the supply of energy to Mycobacterium tuberculosis and most other mycobacteria.
- The Union Health Minister also has launched CBNAAT (Cartridge-Based Nucleic Acid Amplification Test) diagnostic machines for the quick diagnosis of TB within two hours.
- These machines have revolutionised rapid molecular test which detects Mycobacterium tuberculosis and rifampicin drug resistance, simultaneously.
- It will help in treating patients of TB patients promptly and can be used in remote and rural areas without sophisticated infrastructure or specialized training.
TB India 2016 Annual Report
- The Union Health Minister also released the TB India 2016 Annual Report and the technical and operational guidelines for TB Control in India 2016.
- The comprehensive sets of guidelines are for management of all forms of TB and strategies for intensified case finding.
- These guidelines adhere of more patient centric approaches and single-window care for patients suffering from HIV and TB.